(Q46090464)

English

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study

scientific article published on 11 March 2009

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

type 2 diabetes

0 references

0 references

circulatory system

1 reference

based on heuristic

inferred from title

Atrial Fibrillation

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

10

object named as

Pavel Hamet

0 references

object named as

Xin Du

1

0 references

object named as

John Chalmers

5

0 references

12

object named as

Gregory Y H Lip

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

Toshiharu Ninomiya

2

object named as

Toshiharu Ninomiya

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

11

object named as

Neil Poulter

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

13

object named as

Anushka Patel

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

ADVANCE-ON Collaborative Group

14

object named as

ADVANCE Collaborative Group

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

Bastiaan E de Galan

3

object named as

Bastiaan de Galan

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

6

object named as

Avinesh Pillai

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

author name string

Edward Abadir

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

Mark Woodward

7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

Mark Cooper

8

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

publication date

11 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

30

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

9

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

1128-1135

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP055

21 January 2018

Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP055

21 January 2018

Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP055

21 January 2018

Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP055

21 January 2018

Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP055

21 January 2018

Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP055

21 January 2018

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP055

21 January 2018

A community-based educational intervention to improve antithrombotic drug use in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP055

21 January 2018

Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP055

21 January 2018

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP055

21 January 2018

Coronary ischemic events after first atrial fibrillation: risk and survival.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP055

21 January 2018

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP055

21 January 2018

A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP055

21 January 2018

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP055

21 January 2018

New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP055

21 January 2018

Follow-up of atrial fibrillation: The initial experience of the Canadian Registry of Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP055

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHP055

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19282274

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46090464&oldid=2091539543"